File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Traditional Chinese medicine research in the post-genomic era: Good practice, priorities, challenges and opportunities

TitleTraditional Chinese medicine research in the post-genomic era: Good practice, priorities, challenges and opportunities
Authors
Issue Date2012
PublisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/jethpharm
Citation
Journal Of Ethnopharmacology, 2012, v. 140 n. 3, p. 458-468 How to Cite?
AbstractBackground and aims: GP-TCM is the 1st EU-funded Coordination Action consortium dedicated to traditional Chinese medicine (TCM) research. This paper aims to summarise the objectives, structure and activities of the consortium and introduces the position of the consortium regarding good practice, priorities, challenges and opportunities in TCM research. Serving as the introductory paper for the GP-TCM Journal of Ethnopharmacology special issue, this paper describes the roadmap of this special issue and reports how the main outputs of the ten GP-TCM work packages are integrated, and have led to consortium-wide conclusions. Materials and methods: Literature studies, opinion polls and discussions among consortium members and stakeholders. Results: By January 2012, through 3 years of team building, the GP-TCM consortium had grown into a large collaborative network involving ∼200 scientists from 24 countries and 107 institutions. Consortium members had worked closely to address good practice issues related to various aspects of Chinese herbal medicine (CHM) and acupuncture research, the focus of this Journal of Ethnopharmacology special issue, leading to state-of-the-art reports, guidelines and consensus on the application of omics technologies in TCM research. In addition, through an online survey open to GP-TCM members and non-members, we polled opinions on grand priorities, challenges and opportunities in TCM research. Based on the poll, although consortium members and non-members had diverse opinions on the major challenges in the field, both groups agreed that high-quality efficacy/effectiveness and mechanistic studies are grand priorities and that the TCM legacy in general and its management of chronic diseases in particular represent grand opportunities. Consortium members cast their votes of confidence in omics and systems biology approaches to TCM research and believed that quality and pharmacovigilance of TCM products are not only grand priorities, but also grand challenges. Non-members, however, gave priority to integrative medicine, concerned on the impact of regulation of TCM practitioners and emphasised intersectoral collaborations in funding TCM research, especially clinical trials. Conclusions: The GP-TCM consortium made great efforts to address some fundamental issues in TCM research, including developing guidelines, as well as identifying priorities, challenges and opportunities. These consortium guidelines and consensus will need dissemination, validation and further development through continued interregional, interdisciplinary and intersectoral collaborations. To promote this, a new consortium, known as the GP-TCM Research Association, is being established to succeed the 3-year fixed term FP7 GP-TCM consortium and will be officially launched at the Final GP-TCM Congress in Leiden, the Netherlands, in April 2012. © 2012 Elsevier Ireland Ltd. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/179271
ISSN
2015 Impact Factor: 3.055
2015 SCImago Journal Rankings: 1.156
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorUzuner, Hen_US
dc.contributor.authorBauer, Ren_US
dc.contributor.authorFan, TPen_US
dc.contributor.authorGuo, DAen_US
dc.contributor.authorDias, Aen_US
dc.contributor.authorElNezami, Hen_US
dc.contributor.authorEfferth, Ten_US
dc.contributor.authorWilliamson, EMen_US
dc.contributor.authorHeinrich, Men_US
dc.contributor.authorRobinson, Nen_US
dc.contributor.authorHylands, PJen_US
dc.contributor.authorHendry, BMen_US
dc.contributor.authorCheng, YCen_US
dc.contributor.authorXu, Qen_US
dc.date.accessioned2012-12-19T09:53:33Z-
dc.date.available2012-12-19T09:53:33Z-
dc.date.issued2012en_US
dc.identifier.citationJournal Of Ethnopharmacology, 2012, v. 140 n. 3, p. 458-468en_US
dc.identifier.issn0378-8741en_US
dc.identifier.urihttp://hdl.handle.net/10722/179271-
dc.description.abstractBackground and aims: GP-TCM is the 1st EU-funded Coordination Action consortium dedicated to traditional Chinese medicine (TCM) research. This paper aims to summarise the objectives, structure and activities of the consortium and introduces the position of the consortium regarding good practice, priorities, challenges and opportunities in TCM research. Serving as the introductory paper for the GP-TCM Journal of Ethnopharmacology special issue, this paper describes the roadmap of this special issue and reports how the main outputs of the ten GP-TCM work packages are integrated, and have led to consortium-wide conclusions. Materials and methods: Literature studies, opinion polls and discussions among consortium members and stakeholders. Results: By January 2012, through 3 years of team building, the GP-TCM consortium had grown into a large collaborative network involving ∼200 scientists from 24 countries and 107 institutions. Consortium members had worked closely to address good practice issues related to various aspects of Chinese herbal medicine (CHM) and acupuncture research, the focus of this Journal of Ethnopharmacology special issue, leading to state-of-the-art reports, guidelines and consensus on the application of omics technologies in TCM research. In addition, through an online survey open to GP-TCM members and non-members, we polled opinions on grand priorities, challenges and opportunities in TCM research. Based on the poll, although consortium members and non-members had diverse opinions on the major challenges in the field, both groups agreed that high-quality efficacy/effectiveness and mechanistic studies are grand priorities and that the TCM legacy in general and its management of chronic diseases in particular represent grand opportunities. Consortium members cast their votes of confidence in omics and systems biology approaches to TCM research and believed that quality and pharmacovigilance of TCM products are not only grand priorities, but also grand challenges. Non-members, however, gave priority to integrative medicine, concerned on the impact of regulation of TCM practitioners and emphasised intersectoral collaborations in funding TCM research, especially clinical trials. Conclusions: The GP-TCM consortium made great efforts to address some fundamental issues in TCM research, including developing guidelines, as well as identifying priorities, challenges and opportunities. These consortium guidelines and consensus will need dissemination, validation and further development through continued interregional, interdisciplinary and intersectoral collaborations. To promote this, a new consortium, known as the GP-TCM Research Association, is being established to succeed the 3-year fixed term FP7 GP-TCM consortium and will be officially launched at the Final GP-TCM Congress in Leiden, the Netherlands, in April 2012. © 2012 Elsevier Ireland Ltd. All rights reserved.en_US
dc.languageengen_US
dc.publisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/jethpharmen_US
dc.relation.ispartofJournal of Ethnopharmacologyen_US
dc.subject.meshAcupuncture Therapy - Standardsen_US
dc.subject.meshBiomedical Research - Standardsen_US
dc.subject.meshCooperative Behavioren_US
dc.subject.meshDrugs, Chinese Herbal - Standardsen_US
dc.subject.meshEuropean Unionen_US
dc.subject.meshEvidence-Based Medicineen_US
dc.subject.meshGenomicsen_US
dc.subject.meshGuidelines As Topicen_US
dc.subject.meshHumansen_US
dc.subject.meshIntegrative Medicineen_US
dc.subject.meshMedicine, Chinese Traditionalen_US
dc.subject.meshPharmacovigilanceen_US
dc.subject.meshPhytotherapy - Standardsen_US
dc.subject.meshSystems Biologyen_US
dc.titleTraditional Chinese medicine research in the post-genomic era: Good practice, priorities, challenges and opportunitiesen_US
dc.typeArticleen_US
dc.identifier.emailElNezami, H: elnezami@hkucc.hku.hken_US
dc.identifier.authorityElNezami, H=rp00694en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/j.jep.2012.02.028en_US
dc.identifier.pmid22387462-
dc.identifier.scopuseid_2-s2.0-84859004535en_US
dc.identifier.hkuros213411-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-84859004535&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume140en_US
dc.identifier.issue3en_US
dc.identifier.spage458en_US
dc.identifier.epage468en_US
dc.identifier.isiWOS:000302844100002-
dc.publisher.placeIrelanden_US
dc.identifier.scopusauthoridUzuner, H=16069778900en_US
dc.identifier.scopusauthoridBauer, R=7401721175en_US
dc.identifier.scopusauthoridFan, TP=36831423500en_US
dc.identifier.scopusauthoridGuo, DA=35242576200en_US
dc.identifier.scopusauthoridDias, A=7202192555en_US
dc.identifier.scopusauthoridElNezami, H=6603690577en_US
dc.identifier.scopusauthoridEfferth, T=7005243974en_US
dc.identifier.scopusauthoridWilliamson, EM=24432068600en_US
dc.identifier.scopusauthoridHeinrich, M=16156235300en_US
dc.identifier.scopusauthoridRobinson, N=7201402374en_US
dc.identifier.scopusauthoridHylands, PJ=6603546102en_US
dc.identifier.scopusauthoridHendry, BM=7005100278en_US
dc.identifier.scopusauthoridCheng, YC=36041844200en_US
dc.identifier.scopusauthoridXu, Q=7403743653en_US
dc.identifier.citeulike10415097-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats